Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Moderna Inc

Moderna Beats On Q4 Earnings, Announces $3B Buyback; Expects ~$19B In FY22 COVID-19 Vax Sales

Moderna Inc (NASDAQ:MRNA) reports a Q4 EPS of $11.29, a turnaround from an EPS loss of $(0.69) a year ago, beating the consensus estimate of $9.90. The Company clocked Q4 revenues of $7.21 billion compared to just $571 million a year ago, beating the consensus of $6.79 billion. Product sales were $6.9…

Moderna, Thermo Fisher Join Forces To Manufacture COVID-19 Vaccine, Other Drugs

Moderna, Thermo Fisher Join Forces To Manufacture COVID-19 Vaccine, Other Drugs

Moderna Inc (NASDAQ: MRNA) has en

Looking Into Moderna Inc's Recent Short Interest

Looking Into Moderna Inc's Recent Short Interest

Moderna Inc's (NASDAQ:MRNA) short percent of float has fallen 5.45% since its last report. The company recently reported that it has 15.80 million shares sold short, which is 4.51% of all regular shares that are available for trading.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Moderna Adds Three New mRNA-Based Development Programs To Its Pipeline

Moderna Inc (NASDAQ: MRNA) said it is deve

Moderna Says COVID-19 Booster To Be Ready By August, But Dicey If Omicron-Specific Needed: Reuters

Moderna Inc's (NASDAQ: MRNA) CEO, Stephane Bancel, told Reuters that an

Pfizer, Moderna COVID-19 Boosters Effectiveness Wanes After Four Months: CDC Study

COVID-19 vaccine boosters from Pfizer Inc (NYSE: PFE) / BioNTech SE (NASDAQ: BNTX) and Moderna Inc (NASDAQ:

Moderna CEO Sells Shares, Deletes Social Media: What You Need To Know

Moderna Inc (NASDAQ: MRNA) shares are down more than 40% since the start of the year and continue to trend lower Monday.

inkl

Read news from The Economist, FT, and more,
with one subscription

Why Moderna Shares Are Rising Today

Why Moderna Shares Are Rising Today

Moderna Inc (NASDAQ: MRNA) is trading higher Monday after the U.S. Food and Drug Administration approved the Biologics License Application for SPIKEVAX to prevent COVID-19 in individuals 18 years of age and older.

Moderna's COVID-19 Vaccine Becomes Second To Score Complete FDA Approval

Moderna's COVID-19 Vaccine Becomes Second To Score Complete FDA Approval

The FDA has given complete approval to Moderna Inc's (NASDAQ:

IAVI, Moderna Kickstart HIV Vaccine Antigens Trial Delivered Through mRNA Technology

IAVI, Moderna Kickstart HIV Vaccine Antigens Trial Delivered Through mRNA Technology

IAVI, the nonprofit scientific research organization, and Moderna Inc (NASDAQ: MRNA) have

After Pfizer, Moderna Kickstarts Omicron-Targeted COVID-19 Vaccine Trial

After Pfizer, Moderna Kickstarts Omicron-Targeted COVID-19 Vaccine Trial

Moderna Inc (NASDAQ: MRNA) has started a mid-stage study, testing a booster dose of its COVID-19 vaccine specifically

Why Moderna Shares Are Rising

Moderna Inc (NASDAQ: MRNA) shares are trading higher by 7.2% at $163.54 Wednesday afternoon after Deutsche Bank upgraded the stock from Sell to Hold and announced a $175 price target.

Peering Into Moderna Inc's Recent Short Interest

Peering Into Moderna Inc's Recent Short Interest

Moderna Inc's (NASDAQ:MRNA) short percent of float has risen 8.66% since last its last report. The company recently reported that it has 16.69 million shares sold short, which is 4.77% of all regular shares that are available for trading.

Why Moderna, Pfizer, BioNTech And Novavax Shares Are Falling Today

Why Moderna, Pfizer, BioNTech And Novavax Shares Are Falling Today

Shares of vaccine makers, including Moderna Inc (NASDAQ: MRNA), BioNTech SE - ADR (NASDAQ: BNTX) and Novavax, Inc.

Get all your
news in one place.

100’s of premium titles.
One news app.

People

Stephane Bancel

Stéphane Bancel

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Board of Directors

U.S. Food and Drug Administration

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

294,264 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play